Vascular endothelial growth factor and the endometrium.
Smith
S K
SK
Department of Obstetrics and Gynaecology, University of Cambridge School of Clinical Medicine, Rosie Maternity Hospital, UK.
D000818:Animals; D003271:Contraceptive Agents, Female / Q000009:adverse effects; D004717:Endometrium / Q000098:blood supply / Q000187:drug effects / Q000502:physiology*; D016228:Endothelial Growth Factors / Q000737:chemistry / Q000502:physiology*; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000009:adverse effects; D008222:Lymphokines / Q000737:chemistry / Q000502:physiology*; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology*; D045167:Progesterone Congeners / Q000009:adverse effects; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D003271:Contraceptive Agents, Female; D016228:Endothelial Growth Factors; D008222:Lymphokines; D045167:Progesterone Congeners; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016912:Levonorgestrel